Skip to content

Clinical trials

Phase 2 Neoplasm Metastasis trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 2 Country / region: Germany Clear all

76 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20034
20042
20053
20073
20084
20096
20104
20114
20122
20135
20143
20154
20164
20172
20181
20193
20205
20214
20222
20231
20241
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed44
Terminated16
Recruiting5
Active, not recruiting5
Unknown status4
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AIO-Studien-gGmbH5
AstraZeneca5
Bayer3
Eli Lilly and Company3
Merck KGaA, Darmstadt, Germany3
Novartis Pharmaceuticals3
Astellas Pharma Inc2
Clovis Oncology, Inc.2
European Organisation for Research and Treatment of Cancer - EORTC2
GBG Forschungs GmbH2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis76
Breast Neoplasms15
Neoplasms14
Colorectal Neoplasms12
Carcinoma, Non-Small-Cell Lung7
Colonic Neoplasms5
Melanoma5
Recurrence5
Stomach Neoplasms5
Rectal Neoplasms4

Trials

Showing 1 to 25 of 76. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.